News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
644,657 Results
Type
Article (61354)
Company Profile (69)
Press Release (583234)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (173656)
Career Advice (2730)
Deals (32412)
Drug Delivery (97)
Drug Development (76844)
Employer Resources (151)
FDA (14935)
Job Trends (13884)
News (304822)
Policy (28967)
Tag
Academia (2894)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (88)
Alliances (43146)
ALS (88)
Alzheimer's disease (1321)
Antibody-drug conjugate (ADC) (109)
Approvals (14951)
Artificial intelligence (264)
Autoimmune disease (23)
Automation (15)
Bankruptcy (291)
Best Places to Work (10855)
BIOSECURE Act (16)
Biosimilars (101)
Biotechnology (51)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (273)
Cancer (2182)
Cardiovascular disease (165)
Career advice (2313)
Career pathing (33)
CAR-T (154)
Cell therapy (428)
Cervical cancer (20)
Clinical research (62484)
Collaboration (785)
Compensation (324)
Complete response letters (21)
COVID-19 (2578)
CRISPR (43)
C-suite (260)
Cystic fibrosis (100)
Data (2149)
Decentralized trials (2)
Denatured (25)
Depression (44)
Diabetes (252)
Diagnostics (6155)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (113)
Drug pricing (97)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60078)
Editorial (38)
Employer branding (18)
Employer resources (133)
Events (94319)
Executive appointments (760)
FDA (16187)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (746)
Gene editing (109)
Generative AI (20)
Gene therapy (298)
GLP-1 (668)
Government (4460)
Grass and pollen (6)
Guidances (62)
Healthcare (18209)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (108)
Indications (28)
Infectious disease (2711)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (526)
IPO (14783)
IRA (38)
Job creations (3415)
Job search strategy (1942)
Kidney cancer (10)
Labor market (30)
Layoffs (501)
Leadership (22)
Legal (6451)
Liver cancer (70)
Lung cancer (305)
Lymphoma (145)
Machine learning (7)
Management (53)
Manufacturing (275)
MASH (63)
Medical device (12652)
Medtech (12657)
Mergers & acquisitions (18205)
Metabolic disorders (632)
Multiple sclerosis (77)
NASH (13)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1839)
NextGen: Class of 2025 (6379)
Non-profit (4322)
Now hiring (12)
Obesity (321)
Opinion (232)
Ovarian cancer (71)
Pain (91)
Pancreatic cancer (79)
Parkinson's disease (141)
Partnered (21)
Patents (234)
Patient recruitment (111)
Peanut (50)
People (59554)
Pharmaceutical (20)
Pharmacy benefit managers (15)
Phase I (19657)
Phase II (27564)
Phase III (20148)
Pipeline (1140)
Policy (124)
Postmarket research (2468)
Preclinical (8386)
Press Release (67)
Prostate cancer (107)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (360)
Real estate (5988)
Recruiting (62)
Regulatory (20107)
Reports (33)
Research institute (2396)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (68)
Series A (131)
Series B (86)
Service/supplier (9)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3344)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (25)
The Weekly (32)
Vaccines (668)
Venture capitalists (34)
Weight loss (204)
Women's health (31)
Worklife (19)
Date
Today (173)
Last 7 days (822)
Last 30 days (2488)
Last 365 days (30592)
2025 (10110)
2024 (32294)
2023 (36387)
2022 (46610)
2021 (51573)
2020 (50728)
2019 (44788)
2018 (34071)
2017 (30718)
2016 (30064)
2015 (35451)
2014 (28383)
2013 (24955)
2012 (26223)
2011 (26462)
2010 (24935)
Location
Africa (872)
Alabama (54)
Alaska (6)
Arizona (171)
Arkansas (14)
Asia (38043)
Australia (6847)
California (5546)
Canada (1843)
China (486)
Colorado (248)
Connecticut (259)
Delaware (139)
Europe (88516)
Florida (849)
Georgia (199)
Idaho (56)
Illinois (547)
India (25)
Indiana (278)
Iowa (10)
Japan (153)
Kansas (95)
Kentucky (23)
Louisiana (10)
Maine (61)
Maryland (828)
Massachusetts (4013)
Michigan (222)
Minnesota (337)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (57)
New Hampshire (61)
New Jersey (1637)
New Mexico (29)
New York (1627)
North Carolina (956)
North Dakota (9)
Northern California (2406)
Ohio (194)
Oklahoma (15)
Oregon (36)
Pennsylvania (1233)
Puerto Rico (12)
Rhode Island (31)
South America (1178)
South Carolina (17)
South Dakota (1)
Southern California (2121)
Tennessee (95)
Texas (847)
United States (21214)
Utah (172)
Virginia (142)
Washington D.C. (49)
Washington State (510)
West Virginia (3)
Wisconsin (59)
644,657 Results for "university of iowa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Prostate Drugs May Find New Use in Reducing Risk of Dementia: Study
A new observational study from the University of Iowa points to the potential of alpha-blocker drugs, commonly used to treat enlarged prostates, as a preventive therapeutic option for dementia with Lewy bodies.
June 20, 2024
·
2 min read
·
Tristan Manalac
Lone Star Bio
Caris’ Precision Oncology Alliance Welcomes University of Iowa Holden Comprehensive Cancer Center
Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that University of Iowa Holden Comprehensive Cancer Center has joined Caris’ Precision Oncology Alliance™ (POA).
November 16, 2022
·
4 min read
BioMidwest
WishBone Medical Partners With Clubfoot Solutions to Distribute the Iowa Brace for Pediatric Patients in the U.S.
WishBone Medical, Inc. has entered into a distribution agreement with Clubfoot Solutions, naming WishBone the exclusive pediatric medical device manufacturer to offer the Iowa Brace throughout the United States.
January 5, 2023
·
3 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Press Releases
SIFI announces collaboration with the University of California, San Francisco on Acanthamoeba Keratitis
March 19, 2025
·
5 min read
BioMidwest
Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India
Cardio Diagnostics Holdings, Inc . today announced that India’s Patent Office has granted a patent to the University of Iowa Research Foundation (“UIRF”) under patent number 484488, titled “A Kit for Determining Methylation Status of a CpG Dinucleotide and a Genotype of a Single Nucleotide Polymorphism.”
January 8, 2024
·
5 min read
BioMidwest
Iowa Cancer Specialists Helps Cancer Patients Keep Their Hair
Iowa Cancer Specialists announced that The DigniCap® Scalp Cooling System is now available at 1750 E 53rd Street in Davenport to minimize hair loss from chemotherapy.
September 29, 2022
·
1 min read
Genetown
University of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Checkmate Pharmaceuticals, Inc. announced the University of Iowa Holden Comprehensive Cancer Center’s presentation of preliminary data from an investigator-sponsored phase 1/2 trial evaluating vidutolimod, a first-in-class, immunostimulatory, noninfectious virus-like particle containing a CpG-A Toll-like receptor 9 agonist.
May 26, 2022
·
7 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
BioMidwest
Cardio Diagnostics Holdings, Inc Announces Expansion of IP Portfolio in Australia with Notice of Allowance of Patent Application
Cardio Diagnostics Holdings, Inc. announced that Australia’s Patent Office has issued a Notice of Allowance to the University of Iowa Research Foundation for Australian Patent Application No. 2017277666, titled “Compositions and Methods for Detecting Predisposition to Cardiovascular Disease.”
August 2, 2023
·
4 min read
1 of 64,466
Next
